Isomorphic Labs, an AI-first drug design and development company founded by DeepMind founder Sir Demis Hassabis, is reportedly raising $5 billion (£3.75bn) in fresh funding. Isomorphic raised £1.6bn in Series B funding just this summer, following a $600m round completed in March. It could be valued at $50bn (£37bn) by the fundraise if it completes … Continue reading DeepMind founder ‘to raise £3.75bn for Isomorphic Labs’